Pharmaceutical company Galderma has revealed results from its two phase IIIb trials investigating relabotulinumtoxinA for the treatment of glabellar lines and lateral canthal lines. The first phase IIIb, randomised, double-blind,
A US research team has noted that dermal fillers may cause an immune reaction, blocking lymphatic channels.
A study published in the Journal of Cosmetic Dermatology has introduced the Nose Pliability Assessment Scale (NPAS) to be conducted prior to non-surgical rhinoplasties.
The educational content for CCR 2023 has nearly been finalised, with top practitioners and companies showcasing their latest products and clinical research.
Global medical aesthetics business Neauvia hosted a breakfast event to unveil new clinical data surrounding its dermal filler range.
A study published in Skin Health and Disease has revealed that of 655 respondents who were patients who recently received botulinum toxin treatment, 79% reported some form of adverse event.
Training provider Harley Academy has unveiled the Cotofana Anatomy Journal Club (CAJC) in collaboration with scientist and researcher Professor Sebastian Cotofana.
A study published in The European Molecular Biology Organization Journal has shed new light on how botulinum toxin is able to infiltrate neurons in the brain.
Aesthetic practitioner Dr Tapan Patel has launched the EdiPHI initiative of academic meetings, held at PHI Clinic on Harley Street, London.
We bring you the most up-to-date information for the Aesthetics community across a variety of media, including; news, webinars, podcasts, the Journal, reports, interviews and more!
aesthetics Journal
The Aesthetics Journal is the leading monthly publication for the medical aesthetics specialty. It is peer reviewed and spans an incredible volume of topics. Become a member today to receive the monthly print and digital Journal.
0203 096 1228
2nd Floor, Regal House, 70 London Road
Twickenham TW1 3QS, United Kingdom
© 2023 Easyfairs UK Ltd | Registered in England No. 05067979